Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products
How is the Indian pharmaceutical industry adapting to meet new demands?
Newly published research suggests that some excipients may be more "active" than previously thought.
Can a medieval medicament find use as a modern antibacterial?
How can manufacturers avoid frustrating and inadvertent changes to the solid forms of APIs?
It is essential that drug development incorporates the patient view.
We need to optimize and then accelerate HPAPI drug product development. Alyn McNaughton from Lonza tells us more.
Third place in The Medicine Maker 2019 Innovation Awards went to Colorcon’s StarTab – a starch-based excipient for direct compression.
Adding authentication technologies to tablets could further help protect patients against fake drugs.
A position paper outlines why manufacturers must improve data integrity for excipients.
Inhaled administration has the potential to bring benefits to patients – and commercial success to businesses – across a number of therapeutic spaces.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.